HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Remission from transfusion-dependence in a patient with congenital dyserythropoietic anemia (CDA) and increased intensity of iron chelation.

AuthorsAnke K Bergmann, Hannah Tamary, Ellis J Neufeld
JournalPediatric blood & cancer (Pediatr Blood Cancer) Vol. 53 Issue 6 Pg. 1167-8 (Dec 2009) ISSN: 1545-5017 [Electronic] United States
PMID19606459 (Publication Type: Case Reports, Letter)
Chemical References
  • Iron Chelating Agents
  • Siderophores
  • Deferoxamine
Topics
  • Adolescent
  • Anemia, Dyserythropoietic, Congenital (therapy)
  • Blood Transfusion
  • Deferoxamine (therapeutic use)
  • Erythropoiesis (drug effects)
  • Humans
  • Iron Chelating Agents (therapeutic use)
  • Male
  • Remission Induction (methods)
  • Siderophores (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: